Two Sigma Securities’s Trinity Biotech TRIB Stock Holding History

Two Sigma Securities’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-527	Closed	-$12.5K	–	2208
2025 Q4	$12.5K	Buy	527 +119	+29%	+$3.51K	﹤0.01%	1260
2025 Q3	$12.7K	Buy	+408	New	+$12.9K	﹤0.01%	1191
2025 Q2	–	Sell	-585	Closed	-$10K	–	2082
2025 Q1	$10K	Buy	+585	New	+$13.8K	﹤0.01%	1236
2024 Q1	–	Sell	-127	Closed	-$8.17K	–	3658
2023 Q4	$8.17K	Buy	+127	New	+$9.09K	﹤0.01%	2845
2022 Q3	–	Sell	-74	Closed	-$14K	–	3101
2022 Q2	$14K	Buy	+74	New	+$13.6K	﹤0.01%	2006
2021 Q3	–	Sell	-78	Closed	-$34K	–	1961
2021 Q2	$34K	Buy	+78	New	+$38.9K	﹤0.01%	1423
2017 Q3	–	Sell	-98	Closed	-$88K	–	1220
2017 Q2	$88K	Buy	+98	New	+$83.3K	0.02%	669

Other funds holding TRIB

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

YAG

Yorkville Advisors Global Mountainside, New Jersey $155M AUM 58.46% 1-Year Est. Return

Williams & Novak Westlake Village, California $151M AUM 27.43% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

MAWA

Moss Adams Wealth Advisors Seattle, Washington $1.6B AUM 28.24% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

BCM

Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Two Sigma Securities's TRIB Position: Q1 2026 in Review

Two Sigma Securities sold out of Trinity Biotech (TRIB) in Q1 2026, closing a stake of 527 shares — an estimated $12.5K sold.

Two Sigma Securities first reported a position in TRIB in Q2 2017 and held it in 7 quarters. The position peaked at $88K in Q2 2017. 21 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

Two Sigma Securities reported no remaining Trinity Biotech position as of Q1 2026 after selling out during the quarter.
Two Sigma Securities sold 527 Trinity Biotech shares in Q1 2026, an estimated $12.5K.
Two Sigma Securities first reported a position in Trinity Biotech in Q2 2017 and held it in 7 quarters.
Two Sigma Securities's Trinity Biotech position peaked at $88K in Q2 2017.
21 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.